Introduction to a seminar on revisiting the value of PSA-based prostate cancer screening

被引：1
|
作者：
Carlsson, Sigrid, V [1 ,2 ,3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA
[3] Univ Gothenburg, Inst Clin Sci, Dept Urol, Sahlgrenska Acad, Gothenburg, Sweden
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2023年 / 41卷 / 02期
基金：
美国国家卫生研究院;
关键词：
Prostate cancer; Prostate specific antigen; Screening; Magnetic resonance imaging; Early detection;
D O I：
10.1016/j.urolonc.2022.04.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [1] Seminar: Revisiting the value of PSA-based prostate cancer screening Essay No 5: Should men undergo MRI before prostate biopsy? (Pro)
    Maffei, Davide
    Giganti, Francesco
    Moore, Caroline M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (02) : 88 - 91
  • [2] PSA-based screening for prostate cancer: How does it compare with other cancer screening tests?
    Crawford, E. David
    Abrahamsson, Per-Anders
    EUROPEAN UROLOGY, 2008, 54 (02) : 262 - 273
  • [3] Unintended consequences of decreased PSA-based prostate cancer screening
    Ahlering, Thomas
    Huynh, Linda My
    Kaler, Kamaljot S.
    Williams, Stephen
    Osann, Kathryn
    Joseph, Jean
    Lee, David
    Davis, John W.
    Abaza, Ronney
    Kaouk, Jihad
    Patel, Vipul
    Kim, Isaac Yi
    Porter, James
    Hu, Jim C.
    WORLD JOURNAL OF UROLOGY, 2019, 37 (03) : 489 - 496
  • [4] PSA-based early detection of prostate cancer
    Luboldt, HJ
    Rübben, H
    UROLOGE A, 2000, 39 (01): : 22 - 26
  • [5] Unintended consequences of decreased PSA-based prostate cancer screening
    Thomas Ahlering
    Linda My Huynh
    Kamaljot S. Kaler
    Stephen Williams
    Kathryn Osann
    Jean Joseph
    David Lee
    John W. Davis
    Ronney Abaza
    Jihad Kaouk
    Vipul Patel
    Isaac Yi Kim
    James Porter
    Jim C. Hu
    World Journal of Urology, 2019, 37 : 489 - 496
  • [6] Current results on PSA-based prostate cancer detection
    Graefen, M.
    Schlomm, T.
    Steuber, T.
    Sauter, G.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2014, 57 (03) : 312 - 317
  • [7] Finding the PSA-based screening stopping age using prostate cancer risk
    Nahvijou, Azin
    Hadian, Mohammad
    Mohamadkhani, Naser
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2024, 38
  • [8] PSA-based vaccines for the treatment of prostate cancer
    Madan, Ravi A.
    Gulley, James L.
    Arlen, Philip M.
    EXPERT REVIEW OF VACCINES, 2006, 5 (02) : 199 - 209
  • [9] Clinician interest in clinical decision support for PSA-based prostate cancer screening
    Harper, Jonathan
    Hunt, Trevor
    Choudry, Mouneeb
    Kapron, Ashley L.
    Cooney, Kathleen A.
    Martin, Christopher
    Ambrose, Jacob
    O'Neil, Brock
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (03) : 145.e17 - 145.e23
  • [10] PSA-based screening for prostate cancer in asymptomatic younger males: Pilot study in blood donors
    Reissigl, A
    Pointner, J
    Horninger, W
    Strasser, H
    Mayersbach, P
    Klocker, H
    Schonitzer, D
    Bartsch, G
    PROSTATE, 1997, 30 (01) : 20 - 25
12345